The efficacy and safety of long-term oral amiodarone was assessed in 173 patients with
symptomatic tachyarrhythmias: 96 with life-threatening ventricular tachycardia and fibrillation …

Amiodarone was utilized in 70 patients with symptomatic, sustained refractory
tachyarrhythmias. Of these, 29 had atrial arrhythmia (20 recurrent atrial fibrillation and nine …

Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular
tachycardia (VT)(n= 118) or a cardiac arrest (n= 36) and who were refractory to conventional …

Using a high-pressure liquid chromatographic assay, we measured serum amiodarone
concentrations serially in 122 patients treated with amiodarone for 1.5-53 months (mean 9.3 …

Amiodarone, administered orally in doses of 200 to 600 mg/day, was remarkably effective in
the treatment and prevention of a wide variety of atrial and ventricular arrhythmias. Total …

Amiodarone was administered to 121 patients (82 males, 39 females; average age 59
years) with refractory atrial tachyarrhythmias. All patients had experienced recurrent atrial …

Amiodarone has remarkable efficacy, but it also has a high incidence of severe side effects.
Nevertheless, it is extensively used. The findings of an amiodarone treatment follow-up …

The purpose of the present report is to review the available pharmacokinetic informaation on
amiodarone with an emphasis on our own experience in monitoring serum amiodarone …

Amiodarone has been reported to be a remarkably safe and effective drug in the European
and South American experience but American investigators have published conflicting data …

Amiodarone has been hailed as the most effective single antiarrhythmic drug for treatment of
refractory supraventricular and ventricular arrhythmias. However, questions continue to arise …